Correlation
The correlation between TEVA and KVUE is 0.19, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
TEVA vs. KVUE
Compare and contrast key facts about Teva Pharmaceutical Industries Limited (TEVA) and Kenvue Inc. (KVUE).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: TEVA or KVUE.
Performance
TEVA vs. KVUE - Performance Comparison
Loading data...
Key characteristics
TEVA:
-0.01
KVUE:
1.11
TEVA:
0.39
KVUE:
1.82
TEVA:
1.05
KVUE:
1.22
TEVA:
0.00
KVUE:
0.87
TEVA:
0.01
KVUE:
4.53
TEVA:
18.15%
KVUE:
6.32%
TEVA:
48.12%
KVUE:
27.65%
TEVA:
-90.80%
KVUE:
-33.22%
TEVA:
-74.95%
KVUE:
-6.29%
Fundamentals
TEVA:
$20.35B
KVUE:
$45.83B
TEVA:
-$1.15
KVUE:
$0.56
TEVA:
1.29
KVUE:
1.11
TEVA:
1.22
KVUE:
2.99
TEVA:
3.07
KVUE:
4.56
TEVA:
$16.61B
KVUE:
$15.30B
TEVA:
$8.17B
KVUE:
$8.88B
TEVA:
$1.37B
KVUE:
$3.06B
Returns By Period
In the year-to-date period, TEVA achieves a -23.87% return, which is significantly lower than KVUE's 13.90% return.
TEVA
-23.87%
7.43%
-0.00%
-0.89%
22.63%
6.02%
-11.41%
KVUE
13.90%
0.50%
0.98%
28.33%
N/A
N/A
N/A
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
TEVA vs. KVUE — Risk-Adjusted Performance Rank
TEVA
KVUE
TEVA vs. KVUE - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Teva Pharmaceutical Industries Limited (TEVA) and Kenvue Inc. (KVUE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
TEVA vs. KVUE - Dividend Comparison
TEVA has not paid dividends to shareholders, while KVUE's dividend yield for the trailing twelve months is around 3.44%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
TEVA Teva Pharmaceutical Industries Limited | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 4.49% | 3.75% | 2.08% | 2.37% |
KVUE Kenvue Inc. | 3.44% | 3.79% | 1.86% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Drawdowns
TEVA vs. KVUE - Drawdown Comparison
The maximum TEVA drawdown since its inception was -90.80%, which is greater than KVUE's maximum drawdown of -33.22%. Use the drawdown chart below to compare losses from any high point for TEVA and KVUE.
Loading data...
Volatility
TEVA vs. KVUE - Volatility Comparison
Teva Pharmaceutical Industries Limited (TEVA) has a higher volatility of 16.55% compared to Kenvue Inc. (KVUE) at 7.57%. This indicates that TEVA's price experiences larger fluctuations and is considered to be riskier than KVUE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
TEVA vs. KVUE - Financials Comparison
This section allows you to compare key financial metrics between Teva Pharmaceutical Industries Limited and Kenvue Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
TEVA vs. KVUE - Profitability Comparison
TEVA - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2025, Teva Pharmaceutical Industries Limited reported a gross profit of 1.88B and revenue of 3.89B. Therefore, the gross margin over that period was 48.2%.
KVUE - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2025, Kenvue Inc. reported a gross profit of 2.17B and revenue of 3.74B. Therefore, the gross margin over that period was 58.0%.
TEVA - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2025, Teva Pharmaceutical Industries Limited reported an operating income of 519.00M and revenue of 3.89B, resulting in an operating margin of 13.3%.
KVUE - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2025, Kenvue Inc. reported an operating income of 558.00M and revenue of 3.74B, resulting in an operating margin of 14.9%.
TEVA - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2025, Teva Pharmaceutical Industries Limited reported a net income of 214.00M and revenue of 3.89B, resulting in a net margin of 5.5%.
KVUE - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2025, Kenvue Inc. reported a net income of 322.00M and revenue of 3.74B, resulting in a net margin of 8.6%.